Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Ovarian Neoplasms

  Free Subscription


Articles published in Eur J Obstet Gynecol Reprod Biol

Retrieve available abstracts of 42 articles:
HTML format



Single Articles


    June 2022
  1. ROSATI A, Fedele C, Fagotti A, Lafuenti L, et al
    Needleoscopic-assisted risk-reducing bilateral salpingo-oophorectomy in BRCA1/2 mutation carriers: Peri-operative outcomes and psychological impact.
    Eur J Obstet Gynecol Reprod Biol. 2022;273:1-6.
    PubMed     Abstract available


    March 2022
  2. ASSAF W, Andraous M, Lavie O, Segev Y, et al
    Attitudes of Israeli gynecologists towards risk reduction salpingo-oophorectomy at hysterectomy for benign conditions and the use of hormonal therapy.
    Eur J Obstet Gynecol Reprod Biol. 2022;272:48-54.
    PubMed     Abstract available


    February 2022
  3. GRAHAM R, MacDonald ND, Lockley M, Miller R, et al
    Surgical management and outcomes for stage 1 malignant ovarian germ cell tumours: A UK multicentre retrospective cohort study.
    Eur J Obstet Gynecol Reprod Biol. 2022;271:138-144.
    PubMed     Abstract available


    December 2021
  4. SOBICZEWSKI P, Piatek S, Michalski W, Kupryjanczyk J, et al
    Obstetric outcomes after conservative management of ovarian borderline tumors in women of reproductive age: A single center experience.
    Eur J Obstet Gynecol Reprod Biol. 2021;269:126-131.
    PubMed     Abstract available


  5. VALENTI G, Vitagliano A, Morotti M, Giorda G, et al
    Risks factors for anastomotic leakage in advanced ovarian cancer: A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2021;269:3-15.
    PubMed     Abstract available


    November 2021
  6. WANG M, Liu K
    Advances in fertility preserving surgery for borderline ovarian tumors.
    Eur J Obstet Gynecol Reprod Biol. 2021;270:206-211.
    PubMed     Abstract available


  7. SHIGEYAMA M, Yoshihara M, Kitami K, Mogi K, et al
    Long-term post-recurrence survival outcomes in young women receiving fertility-sparing surgery for epithelial ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2021;267:221-225.
    PubMed     Abstract available


  8. LIANG X, Zeng H, Chen S, Jiang M, et al
    Ovarian metastasis risk factors in endometrial carcinoma: A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2021;267:245-255.
    PubMed     Abstract available


  9. CHEN Y, Han L, Zheng A
    Association between statin use and the risk, prognosis of gynecologic cancer: A meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2021;268:74-81.
    PubMed     Abstract available


    October 2021
  10. OU YC, Fu HC, Lan J, Wu CH, et al
    The role of prolonged progestin treatment and factors predicting successful fertility-sparing treatment for early endometrial endometrioid adenocarcinoma.
    Eur J Obstet Gynecol Reprod Biol. 2021;267:99-104.
    PubMed     Abstract available


  11. FRIEDRICH L, Meyer R, Levin G
    Management of adnexal mass: A comparison of five national guidelines.
    Eur J Obstet Gynecol Reprod Biol. 2021;265:80-89.
    PubMed     Abstract available


  12. KERSHAW V, Hickey I, Wyld L, Jha S, et al
    The impact of risk reducing bilateral salpingo-oophorectomy on sexual function in BRCA1/2 mutation carriers and women with Lynch syndrome: A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2021;265:7-17.
    PubMed     Abstract available


  13. JEFFERY HE, Gillespie AM, Macdonald M
    Evaluation of women referred to the two-week wait gynaecology clinic with suspected ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2021;266:145-149.
    PubMed     Abstract available


    August 2021
  14. LIU G, Wang Y, Chen Y, Ren F, et al
    Malignant transformation of abdominal wall endometriosis: A systematic review of the epidemiology, diagnosis, treatment, and outcomes.
    Eur J Obstet Gynecol Reprod Biol. 2021;264:363-367.
    PubMed     Abstract available


    July 2021
  15. SHARMA JB, Kumar R, Singh U, Kumari A, et al
    Pre treatment and post treatment positron emission tomography-computed tomography (PET-CT) to evaluate treatment response in tuberculous Tubo-Ovarian masses.
    Eur J Obstet Gynecol Reprod Biol. 2021;264:128-134.
    PubMed     Abstract available


  16. KANNEGANTI A, Bhadiraju P, Tong PSY
    Extragonadal teratomas in women and adolescent girls: A systematic review.
    Eur J Obstet Gynecol Reprod Biol. 2021;262:134-141.
    PubMed     Abstract available


    June 2021
  17. NEF J, Huber DE
    Ovarian Sertoli-Leydig cell tumours: A systematic review of relapsed cases.
    Eur J Obstet Gynecol Reprod Biol. 2021;263:261-274.
    PubMed     Abstract available


    April 2021
  18. CHOU HH, Chen WC, Yang LY, Huang HJ, et al
    Postoperative adjuvant dose-dense chemotherapy with bevacizumab and maintenance bevacizumab after neoadjuvant chemotherapy for advanced ovarian cancer: A phase II AGOG/TGOG trial.
    Eur J Obstet Gynecol Reprod Biol. 2021;262:13-20.
    PubMed     Abstract available


  19. ATHEY RA, Macdonald MC, Jha S
    Stage of ovarian cancer at diagnosis. Does presentation as an emergency make a difference?
    Eur J Obstet Gynecol Reprod Biol. 2021;261:7-11.
    PubMed     Abstract available


    March 2021
  20. ALMAHDY AM, Elassall GM, Abdelbadee AY, Abd-Elkariem AY, et al
    Prognostic value of systematic lymphadenectomy in patients with ovarian cancer: A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2021;267:179-185.
    PubMed     Abstract available


  21. GKROZOU F, Pappa C, Tsonis O, Dimitriou E, et al
    Relaxin as a potential diagnostic biomarker for ovarian cancer- A prospective study.
    Eur J Obstet Gynecol Reprod Biol. 2021;260:99-104.
    PubMed     Abstract available


    February 2021
  22. CAPMAS P, Suarthana E, Tulandi T
    Further evidence that endometriosis is related to tubal and ovarian cancers: A study of 271,444 inpatient women.
    Eur J Obstet Gynecol Reprod Biol. 2021;260:105-109.
    PubMed     Abstract available


    November 2020
  23. ZHANG JL, Li DF, Li DY, Ma LG, et al
    A rare malignant transformation of endometriosis.
    Eur J Obstet Gynecol Reprod Biol. 2020 Nov 27. pii: S0301-2115(20)30741.
    PubMed    


  24. BOURDEL N, Huchon C, Abdel Wahab C, Azais H, et al
    Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).
    Eur J Obstet Gynecol Reprod Biol. 2020 Nov 20. pii: S0301-2115(20)30758.
    PubMed     Abstract available


  25. CARBONE MV, Cavaliere AF, Fedele C, Vidiri A, et al
    Uterine tumor resembling ovarian sex-cord tumor: Conservative surgery with successful delivery and case series.
    Eur J Obstet Gynecol Reprod Biol. 2020;256:326-332.
    PubMed     Abstract available


  26. ZILLIOX M, Lecointre L, Azais H, Ballester M, et al
    Management of borderline ovarian tumours during pregnancy: Results of a French multi-centre study.
    Eur J Obstet Gynecol Reprod Biol. 2020;256:412-418.
    PubMed     Abstract available


  27. VOUTSADAKIS IA
    A systematic review and meta-analysis of hormone receptor expression in low-grade serous ovarian carcinoma.
    Eur J Obstet Gynecol Reprod Biol. 2020;256:172-178.
    PubMed     Abstract available


  28. TANG X, Zhang X, Liu X, Zheng T, et al
    A novel laparoscopy-based model for the prediction of optimal cytoreduction and prognosis of epithelial ovarian cancer in a Chinese population.
    Eur J Obstet Gynecol Reprod Biol. 2020;256:256-262.
    PubMed     Abstract available


  29. FONNES T, Telle IO, Forsse D, Falck R, et al
    Cancer awareness in the general population varies with sex, age and media coverage: A population-based survey with focus on gynecologic cancers.
    Eur J Obstet Gynecol Reprod Biol. 2020;256:25-31.
    PubMed     Abstract available


    October 2020
  30. KONSGEN D, Klinkmann G, Kaul A, Diesing K, et al
    Soluble heat-shock protein 27 in blood serum is a non-invasive prognostic biomarker for ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2020;255:154-159.
    PubMed     Abstract available


  31. KOLEHMAINEN AM, Pasanen AM, Koivisto-Korander RL, Butzow RC, et al
    Molecular characterization in the prediction of disease extent in endometrial carcinoma.
    Eur J Obstet Gynecol Reprod Biol. 2020 Oct 16. pii: S0301-2115(20)30669.
    PubMed     Abstract available


  32. ZHAO J, Wu J, Zuo W, Kang S, et al
    A functional polymorphism in the poly(ADP-ribose) polymerase-1 gene is associated with platinum-based chemotherapeutic response and prognosis in epithelial ovarian cancer patients.
    Eur J Obstet Gynecol Reprod Biol. 2020;255:183-189.
    PubMed     Abstract available


  33. FERRARI F, Ficarelli S, Forte S, Valenti G, et al
    Extra-abdominal ovarian cancer presenting with breast metastases at diagnosis: Case report and literature review.
    Eur J Obstet Gynecol Reprod Biol. 2020;255:211-221.
    PubMed     Abstract available


    September 2020
  34. YOSHIHARA M, Tamauchi S, Iyoshi S, Kitami K, et al
    Does uterine preservation affect survival outcomes of patients with stage I ovarian sex cord-stromal cell tumours? A multi-institutional study.
    Eur J Obstet Gynecol Reprod Biol. 2020;254:52-56.
    PubMed     Abstract available


    August 2020
  35. CHEN S, Yang B, Fan J
    Diagnostic value of Anti-Mullerian hormone in ovarian granulosa cell tumor: A meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2020;253:266-272.
    PubMed     Abstract available


    July 2020
  36. KHIAT S, Provansal M, Bottin P, Saias-Magnan J, et al
    Fertility preservation after fertility-sparing surgery in women with borderline ovarian tumours.
    Eur J Obstet Gynecol Reprod Biol. 2020;253:65-70.
    PubMed     Abstract available


    March 2020
  37. CHEVROT A, Hequet D, Fauconnier A, Huchon C, et al
    Impact of surgical restaging on recurrence in patients with borderline ovarian tumors: A meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2020;248:227-232.
    PubMed     Abstract available


    January 2020
  38. RUDAITIS V, Mikliusas V, Januska G, Jukna P, et al
    The incidence of occult ovarian neoplasia and cancer in BRCA1/2 mutation carriers after the bilateral prophylactic salpingo-oophorectomy (PBSO): A single-center prospective study.
    Eur J Obstet Gynecol Reprod Biol. 2020;247:26-31.
    PubMed     Abstract available


  39. NASIOUDIS D, Mastroyannis SA, Haggerty AF, Giuntoli RL 2nd, et al
    Fertility preserving surgery for high-grade epithelial ovarian carcinoma confined to the ovary.
    Eur J Obstet Gynecol Reprod Biol. 2020;248:63-70.
    PubMed     Abstract available


    November 2019
  40. OTIFY M, Laios A, Elshamy T, D'Angelo A, et al
    A systematic review and meta-analysis of the use of ultrasound to diagnose borderline ovarian tumours.
    Eur J Obstet Gynecol Reprod Biol. 2019;244:120-127.
    PubMed     Abstract available


  41. TARANNUM A, Sheikh H, Appiah-Sakyi K, Lindow SW, et al
    The diagnostic use of magnetic resonance imaging for acute abdominal and pelvic pain in pregnancy.
    Eur J Obstet Gynecol Reprod Biol. 2019 Nov 22. pii: S0301-2115(19)30542.
    PubMed     Abstract available


  42. RETTENMAIER MA, Micha JP, Bohart R, Goldstein BH, et al
    A retrospective study comparing the efficacy of dose-dense chemotherapy, intraperitoneal chemotherapy and dose-dense chemotherapy with hyperthermic intraperitoneal chemotherapy in the treatment of advanced stage ovarian carcinoma.
    Eur J Obstet Gynecol Reprod Biol. 2019;244:101-105.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: